WeChat Mini Program
Old Version Features

Final Results of the IFCT-0803 Study, a Phase II Study of Cetuximab, Pemetrexed, Cisplatin, and Concurrent Radiotherapy in Patients with Locally Advanced, Unresectable, Stage III, Non-Squamous, Non-Small-cell Lung Cancer.

J. Tredaniel,F. Barlesi,C. Le Pechoux,D. Lerouge,E. Pichon,S. Le Moulec,L. Moreau,S. Friard,V. Westeel,L. Petit,O. Carre,F. Guichard,O. Raffy, J. Villa,A. Prevost,A. Langlais,F. Morin,M. Wislez,P. Giraud,G. Zalcman,F. Mornex, for the French Cooperative Thoracic Intergroup (IFCT) French Cooperat Thoracic Intergrp IFCT

Cancer/Radiothérapie（2022）

Cited 1|Views23
Key words
Stage III NSCLC,Concurrent chemoradiotherapy,Cetuximab,Pemetrexed,Cisplatin
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined